Skip to content
10-K

Annual Report

NEPHROS, INC. NEPH

0001641172-25-000234

← back to feed
Filed
Mar 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 17, 2025 10.6M sh
Shares Diluted FY 2024 · Dec 31, 2023 10.39M sh
Capex FY 2024 · Dec 31, 2023 $75K
Operating Cash Flow FY 2024 · Dec 31, 2023 $827K
Cash And Equivalents FY 2024 · Dec 31, 2023 $4.31M
Current Liabilities FY 2024 · Dec 31, 2023 $2.11M
Total Liabilities FY 2024 · Dec 31, 2023 $3.5M
Current Assets FY 2024 · Dec 31, 2023 $8.41M
Total Assets FY 2024 · Dec 31, 2023 $11.86M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.15
Eps Basic FY 2024 · Dec 31, 2023 −$0.15
Sga Expense FY 2024 · Dec 31, 2023 $8.91M
Rd Expense FY 2024 · Dec 31, 2023 $873K
Net Income FY 2024 · Dec 31, 2023 −$1.58M
Operating Income FY 2024 · Dec 31, 2023 −$1.59M
Gross Profit FY 2024 · Dec 31, 2023 $8.41M
Cost Of Revenue FY 2024 · Dec 31, 2023 $5.83M
Revenue FY 2024 · Dec 31, 2023 $14.24M